Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications using diffusion innovation theory understand challenges opportunities advancing use
… A Cost-Effectiveness Analysis Using Real-World Data William Herring, PhD Director, Health … RTI Health Solutions A Cost-Effectiveness Analysis Using Real-World Data from the MSBase Registry: Comparing … represents an important step forward as the first study to use real-world effectiveness data in an economic evaluation …
… Among HCPs and Consumers OPPORTUNITY Our client needed to understand healthcare professionals (HCP) knowledge, … milestones across the studies, while meeting deadlines for publications. OUR APPROACH We assembled a core team of …
… systematic reviews and meta-analyses to help your team understand the continually evolving body of evidence in a … definitions, etiology, and diagnosis of a disease Understand epidemiologic , humanistic, and economic burden … area Develop economic model inputs including resource use, cost, and utility estimates Identify health disparities …
… Causal Inference Using Real-World Data: How Pharmacoepidemiology Studies Can … MD, PhD As the availability of real-world data grows, opportunities to leverage it are growing Healthcare … receive different treatments. Avoiding Bias However, when using RWD to answer causal questions, there are several …
… How Are Companies Responding to Expected Challenges with Joint Clinical Assessments? Share on: … functions on an EU level. Given the timeline and scoping challenges, success will depend on anticipating the PICOs …
… key role. Often an important step in helping stakeholders understand the relevance of PROs, is to demonstrate the … goal for this study, was to demonstrate the advantages of using longitudinal data methods- and particularly a joint … this article helps researchers understand the value of using more robust analysis approaches, such as the joint …
… Webinar: Economic Modelling Challenges in Rare Diseases Share on: Wednesday, February … HTA bodies appraise rare disease drugs? What are the key challenges to developing cost-effectiveness models? How do we overcome these HTA economic modelling challenges? …
The power of knowledge. The value of understanding. Generating knowledge and providing greater understanding so that life science and healthcare stakeholders—developers, regulators, payers, providers, and patients—can make better …
… Working on EMA-funded Project to Aid Real-World Data Use Share on: February 1, 2021 The European Medicines Agency … employ information from observational studies designed to understand the use of medications in clinical practice, provide critical …
… Objection Handlers Objection handlers are for reactive use when your teams are challenged by payers and need to … Your Value Story: Key Questions to Answer To fully understand your product’s value story, you need to take into …